Skip to main content
Decision support · Not medical advice

Inspire or Genio?

Six questions. You'll see where your answers fall against each device's FDA-approved range — and, separately, against what insurers actually cover. Those two are not the same thing, and the gap is where most people get caught out.

Free, anonymous, and no email required to see your result.

Why this exists. Inspire's FDA approval was widened in 2023 to an AHI of 100 and a BMI of 40. Medicare's hypoglossal nerve stimulation policy still covers an AHI of 15 to 65, from age 22. So it is entirely possible to be approved for a device on the label and denied for it by your plan. Every comparison we could find shows the labels and stops there.
1

Where are you with CPAP?

Almost every insurer requires this before approving an implant.

2

Do you know your AHI from your sleep study?

Apnea-Hypopnea Index — events per hour. It's on your sleep study report.

3

Do you know your BMI?

4

How old are you?

5

Do you need MRI scans regularly?

Both implants have MRI conditions, and they differ.

6

Which would you rather live with?

Genio uses a disposable patch each night. Inspire has an implanted battery and a remote.

Answer all six to continue. "I don't know" is a valid answer.

Disclosure: Dr. Jain is a paid speaker and advisor for pharmaceutical and device manufacturers. These relationships are disclosed in full on our About page and do not change our clinical recommendations. These relationships are listed in full on our About page and do not change our clinical recommendations.

This tool compares your answers against published FDA indications and typical payer policy. It does not diagnose, does not determine candidacy, and is not a treatment recommendation. Candidacy for either implant requires a sleep study, a physical examination and a drug-induced sleep endoscopy. Payer policies vary — your own plan governs. See the full device comparison.